Daniel López‐Trabada

1.0k total citations
10 papers, 174 citations indexed

About

Daniel López‐Trabada is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Daniel López‐Trabada has authored 10 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 3 papers in Genetics. Recurrent topics in Daniel López‐Trabada's work include Genetic factors in colorectal cancer (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and BRCA gene mutations in cancer (3 papers). Daniel López‐Trabada is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and BRCA gene mutations in cancer (3 papers). Daniel López‐Trabada collaborates with scholars based in France, Spain and United Kingdom. Daniel López‐Trabada's co-authors include Romain Cohen, Thierry André, Alex Duval, Yann Parc, Pauline Afchain, Magali Svrcek, Isabelle Trouilloud, Raphaël Colle, Jérémie H. Lefèvre and Olivier Lascols and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Daniel López‐Trabada

8 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel López‐Trabada France 5 114 103 51 29 22 10 174
Alicia Latham United States 7 75 0.7× 112 1.1× 84 1.6× 46 1.6× 41 1.9× 26 209
Dong-Geng Liu China 5 59 0.5× 92 0.9× 70 1.4× 23 0.8× 30 1.4× 6 145
Arun Nagarajan United States 7 161 1.4× 39 0.4× 89 1.7× 46 1.6× 31 1.4× 25 211
Eric Q. Konnick United States 4 79 0.7× 65 0.6× 80 1.6× 62 2.1× 16 0.7× 21 162
Shannon van Vliet Netherlands 9 116 1.0× 91 0.9× 65 1.3× 31 1.1× 53 2.4× 17 225
Paolo Sgargi Italy 7 84 0.7× 30 0.3× 40 0.8× 20 0.7× 25 1.1× 17 138
Jennifer Borowsky Australia 8 108 0.9× 69 0.7× 13 0.3× 41 1.4× 27 1.2× 10 174
Lik Hang Lee United States 6 223 2.0× 121 1.2× 33 0.6× 36 1.2× 61 2.8× 13 265
Daniela Dinu Romania 7 101 0.9× 77 0.7× 43 0.8× 37 1.3× 29 1.3× 15 191
Zorka Inić Serbia 5 92 0.8× 24 0.2× 69 1.4× 29 1.0× 18 0.8× 16 183

Countries citing papers authored by Daniel López‐Trabada

Since Specialization
Citations

This map shows the geographic impact of Daniel López‐Trabada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel López‐Trabada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel López‐Trabada more than expected).

Fields of papers citing papers by Daniel López‐Trabada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel López‐Trabada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel López‐Trabada. The network helps show where Daniel López‐Trabada may publish in the future.

Co-authorship network of co-authors of Daniel López‐Trabada

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel López‐Trabada. A scholar is included among the top collaborators of Daniel López‐Trabada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel López‐Trabada. Daniel López‐Trabada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
López‐Trabada, Daniel, et al.. (2023). Tolérance et efficacité des inhibiteurs de points de contrôle immunitaire en monothérapie chez les patients âgés. Bulletin du Cancer. 110(11). 1204–1214.
2.
López‐Trabada, Daniel, et al.. (2022). Traitement oncologique médical du cancer colorectal chez la personne âgée. Soins Gérontologie. 27(154). 15–19.
3.
Éderhy, Stéphane, et al.. (2018). La toxicité cardiaque des fluoropyrimidines : 5-fluorouracile, capécitabine, le composé S-1 et le trifluridine/tipiracil. Bulletin du Cancer. 105(7-8). 707–719. 9 indexed citations
4.
Cohen, Romain, Anna Pellat, Magali Svrcek, et al.. (2018). Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency. Bulletin du Cancer. 106(2). 137–142. 15 indexed citations
5.
Cohen, Romain, Olivier Buhard, Pascale Cervera, et al.. (2017). Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. European Journal of Cancer. 86. 266–274. 66 indexed citations
6.
Lacy, Jill, Fabienne Portales, Pascal Hammel, et al.. (2017). Interim results of a multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC).. Journal of Clinical Oncology. 35(4_suppl). 358–358. 3 indexed citations
7.
Colle, Raphaël, Romain Cohen, Alex Duval, et al.. (2016). Immunotherapy and patients treated for cancer with microsatellite instability. Bulletin du Cancer. 104(1). 42–51. 69 indexed citations
8.
Márquez‐Rodas, Iván, Sara López‐Tarruella, Yolanda Jerez, et al.. (2013). Evaluation of a Heredofamilial Cancer Unit in Increasing Family History Collection and Genetic Counseling Referrals Among Spanish Oncologists at a University Hospital. Journal of Genetic Counseling. 23(1). 108–113. 4 indexed citations
10.
Márquez‐Rodas, Iván, Ana Blanco, Beatriz Moya, et al.. (2012). The Implementation of a Multidisciplinary Heredofamilial Cancer Unit Changes Hereditary Cancer Risk Perception among Oncologists. Annals of Oncology. 23. ix176–ix177. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026